These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Debrisoquine hydroxylation phenotype, acetylation phenotype, and ABO blood groups as genetic host factors of lung cancer risk. Roots I; Drakoulis N; Ploch M; Heinemeyer G; Loddenkemper R; Minks T; Nitz M; Otte F; Koch M Klin Wochenschr; 1988; 66 Suppl 11():87-97. PubMed ID: 2846954 [TBL] [Abstract][Full Text] [Related]
12. Correlation of polymorphic expression of CYP2D6 mRNA in bladder mucosa and tumor tissue to in vivo debrisoquine hydroxylase activity. Romkes-Sparks M; Mnuskin A; Chern HD; Persad R; Fleming C; Sibley GN; Smith P; Wilkinson GR; Branch RA Carcinogenesis; 1994 Sep; 15(9):1955-61. PubMed ID: 7923590 [TBL] [Abstract][Full Text] [Related]
13. Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis. Dahl ML; Johansson I; Bertilsson L; Ingelman-Sundberg M; Sjöqvist F J Pharmacol Exp Ther; 1995 Jul; 274(1):516-20. PubMed ID: 7616439 [TBL] [Abstract][Full Text] [Related]
14. Debrisoquine oxidation in Parkinson's disease. Kallio J; Marttila RJ; Rinne UK; Sonninen V; Syvälahti E Acta Neurol Scand; 1991 Mar; 83(3):194-7. PubMed ID: 2031454 [TBL] [Abstract][Full Text] [Related]
15. Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility. Buchert ET; Woosley RL; Swain SM; Oliver SJ; Coughlin SS; Pickle L; Trock B; Riegel AT Pharmacogenetics; 1993 Dec; 3(6):322-7. PubMed ID: 8148873 [No Abstract] [Full Text] [Related]
16. Involvement of CYP2D6 but not CYP2C19 in nicergoline metabolism in humans. Böttiger Y; Dostert P; Benedetti MS; Bani M; Fiorentini F; Casati M; Poggesti I; Alm C; Alvan G; Bertilsson L Br J Clin Pharmacol; 1996 Dec; 42(6):707-11. PubMed ID: 8971425 [TBL] [Abstract][Full Text] [Related]
17. Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolizers of debrisoquine. Speirs CJ; Murray S; Boobis AR; Seddon CE; Davies DS Br J Clin Pharmacol; 1986 Dec; 22(6):739-43. PubMed ID: 3567021 [TBL] [Abstract][Full Text] [Related]